GE HealthCare Technologies layoffs, on the record
Every job cut, severance charge and restructuring GE HealthCare Technologies reported in its annual reports, 2023 to 2025, quoted from the filings.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 10,300 | — |
Job cuts, severance and restructuring
Our summaryRecorded restructuring costs for restructuring initiatives committed to by management, mostly workforce reductions, organizational realignments and real estate changes.
Word for word“For restructuring initiatives committed to by management through December 31, 2023, we recorded net expenses of $ 54 million, $ 146 million, and $ 155 million for the years ended December 31, 2023, 2022, and 2021.” 10-K for 2023
Our summaryExpects additional restructuring expenses from initiatives already committed to, mainly for employee termination benefits and facility exit costs.
Word for word“These restructuring initiatives are expected to result in additional expenses of approximately $ 20 million, to be incurred primarily over the next 12 months, substantially related to employee-related termination benefits and facility exit costs.” 10-K for 2023
Our summaryRecorded employee termination costs within restructuring and other activities.
Word for word“Employee termination costs $ 38 $ 74 $ 127 Facility and other exit costs 3 46 20 Asset write-downs 13 26 8 Total restructuring and other activities – net $ 54 $ 146 $ 155 In connection with the Spin-Off, GE transferred employee termination obligations for services already rendered of $ 31 million to GE HealthCare of which $ 4 million was remaining as of December 31, 2023.” 10-K for 2023
Our summaryRecorded restructuring liabilities for employee termination and exit costs, carried in current and non-current liabilities.
Word for word“Liabilities related to restructuring are recognized within All other current liabilities and All other liabilities in the Consolidated and Combined Statements of Financial Position and totaled $ 68 million and $ 75 million as of December 31, 2023 and 2022, respectively.” 10-K for 2023
Our summaryThe filing reports restructuring costs of $120 million in 2024, consisting of severance, facility closures, and other charges associated with restructuring programs.
Word for word“Add: Restructuring costs (1) 120 54 146 Add: Acquisition and disposition-related charges (benefits) (2) 3 (15) (34) Add: Spin-Off and separation costs (3) 251 270 14 Add: (Gain) loss on business and asset dispositions (4) — — (1) Add: Amortization of acquisition-related intangible assets 137 127 121 Add: Investment revaluation (gain) loss (5) 22 (1) 31 Adjusted EBIT* $ 3,211 $ 2,956 $ 2,861 9% 3% Net income margin 10.1% 8.0% 10.4% 210 bps (240) bps Adjusted EBIT margin* 16.3% 15.1% 15.6% 120 bps (50) bps (1) Consists of severance, facility closures, and other charges associated with restructuring programs.” 10-K for 2024
Our summaryThe filing says total operating expenses rose partly because of increased restructuring spend, offset by cost saving initiatives in SG&A.
Word for word“Total operating expenses increased $93 million, with an increase in R&D investments of $106 million and a decrease in Selling, general, and administrative (“SG&A”) expense of $13 million primarily driven by cost saving initiatives, including information technology, largely offset by increased restructuring spend.” 10-K for 2024
| Fiscal year ended | Severance costs | Restructuring charges |
|---|---|---|
| 2021-12-31 | $127 million | $155 million |
| 2022-12-31 | $74 million | $146 million |
| 2023-12-31 | $38 million | $37 million |
| 2024-12-31 | $85 million | $93 million |
| 2025-12-31 | $100 million | $102 million |
GE HealthCare Technologies has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from GE HealthCare Technologies’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-04. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.